Circuit 2, station 2

Which subgroup of patients with heart disease requires special consideration for the management of infective endocarditis (IE)? 

What is the general recommendation for preventing infections in routine treatments? 

In non-routine management, if prophylactic antibiotics are not available in the office, what should be done prior to invasive treatment? 

Which patients are included in the special consideration subgroup for infective endocarditis prevention? 

What is recommended for high-risk patients who are not included in the special consideration subgroup but wish to receive antibiotic prophylaxis?